{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:08:32Z","timestamp":1783102112505,"version":"3.54.6"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s11154-021-09685-7","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T12:02:48Z","timestamp":1631793768000},"page":"431-447","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The role of transforming growth factor beta in thyroid autoimmunity: current knowledge and future perspectives"],"prefix":"10.1007","volume":"23","author":[{"given":"Efstratios","family":"Kardalas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Sakkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Ruchala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djuro","family":"Macut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Mastorakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,16]]},"reference":[{"issue":"16","key":"9685_CR1","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1056\/NEJMra1510030","volume":"375","author":"TJ Smith","year":"2016","unstructured":"Smith TJ, Hegedus L. Graves\u2019 disease. N Engl J Med. 2016;375(16):1552\u201365. https:\/\/doi.org\/10.1056\/NEJMra1510030.","journal-title":"N Engl J Med"},{"key":"9685_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27180","author":"Q Li","year":"2018","unstructured":"Li Q, Wang B, Mu K, Zhang J-A. The pathogenesis of thyroid autoimmune diseases: new T lymphocytes\u2014cytokines circuits beyond the Th1\u2212Th2 paradigm. J Cell Physiol. 2018. https:\/\/doi.org\/10.1002\/jcp.27180.","journal-title":"J Cell Physiol"},{"issue":"1","key":"9685_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2020.101388","volume":"34","author":"A Antonelli","year":"2020","unstructured":"Antonelli A, et al. Graves\u2019 disease: clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy. Best Pract Res Clin Endocrinol Metab. 2020;34(1): 101388. https:\/\/doi.org\/10.1016\/j.beem.2020.101388.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"8","key":"9685_CR4","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1089\/thy.2006.0299","volume":"17","author":"L Papanastasiou","year":"2007","unstructured":"Papanastasiou L, et al. Thyroid autoimmunity in the current iodine environment. Thyroid. 2007;17(8):729\u201339. https:\/\/doi.org\/10.1089\/thy.2006.0299.","journal-title":"Thyroid"},{"issue":"6","key":"9685_CR5","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1210\/jcem.83.6.4853","volume":"83","author":"N Mitsiades","year":"1998","unstructured":"Mitsiades N, et al. Fas\/Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto\u2019s thyroiditis. J Clin Endocrinol Metab. 1998;83(6):2199\u2013203. https:\/\/doi.org\/10.1210\/jcem.83.6.4853.","journal-title":"J Clin Endocrinol Metab"},{"key":"9685_CR6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jaut.2015.07.009","volume":"64","author":"HJ Lee","year":"2015","unstructured":"Lee HJ, et al. Immunogenetics of autoimmune thyroid diseases: a comprehensive review. J Autoimmun. 2015;64:82\u201390. https:\/\/doi.org\/10.1016\/j.jaut.2015.07.009.","journal-title":"J Autoimmun"},{"issue":"6","key":"9685_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2019.101367","volume":"33","author":"F Ragusa","year":"2019","unstructured":"Ragusa F, et al. Hashimotos\u2019 thyroiditis: epidemiology, pathogenesis, clinic and therapy. Best Pract Res Clin Endocrinol Metab. 2019;33(6):101367. https:\/\/doi.org\/10.1016\/j.beem.2019.101367.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"8","key":"9685_CR8","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJMra0905750","volume":"362","author":"RS Bahn","year":"2010","unstructured":"Bahn RS. Graves\u2019 ophthalmopathy. N Engl J Med. 2010;362(8):726\u201338. https:\/\/doi.org\/10.1056\/NEJMra0905750.","journal-title":"N Engl J Med"},{"issue":"3","key":"9685_CR9","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1167\/iovs.14-14002","volume":"55","author":"Y Wang","year":"2014","unstructured":"Wang Y, Smith TJ. Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy. Invest Ophthalmol Vis Sci. 2014;55(3):1735\u201348. https:\/\/doi.org\/10.1167\/iovs.14-14002.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9685_CR10","doi-asserted-by":"publisher","first-page":"7010196","DOI":"10.1155\/2018\/7010196","volume":"2018","author":"N Turck","year":"2018","unstructured":"Turck N, et al. Thyroid-associated orbitopathy and biomarkers: where we are and what we can hope for the future. Dis Markers. 2018;2018:7010196. https:\/\/doi.org\/10.1155\/2018\/7010196.","journal-title":"Dis Markers"},{"key":"9685_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01380-9","author":"T Diana","year":"2020","unstructured":"Diana T, Ponto KA, Kahaly GJ. Thyrotropin receptor antibodies and Graves\u2019 orbitopathy. J Endocrinol Invest. 2020. https:\/\/doi.org\/10.1007\/s40618-020-01380-9.","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"9685_CR12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41574-019-0305-4","volume":"16","author":"PN Taylor","year":"2020","unstructured":"Taylor PN, et al. New insights into the pathogenesis and nonsurgical management of Graves orbitopathy. Nat Rev Endocrinol. 2020;16(2):104\u201316. https:\/\/doi.org\/10.1038\/s41574-019-0305-4.","journal-title":"Nat Rev Endocrinol"},{"key":"9685_CR13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jcte.2016.11.001","volume":"6","author":"E Tingi","year":"2016","unstructured":"Tingi E, et al. Benign thyroid disease in pregnancy: a state of the art review. J Clin Transl Endocrinol. 2016;6:37\u201349. https:\/\/doi.org\/10.1016\/j.jcte.2016.11.001.","journal-title":"J Clin Transl Endocrinol"},{"key":"9685_CR14","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1196\/annals.1365.029","volume":"1092","author":"N Vitoratos","year":"2006","unstructured":"Vitoratos N, et al. Reproductive corticotropin-releasing hormone. Ann N Y Acad Sci. 2006;1092:310\u20138. https:\/\/doi.org\/10.1196\/annals.1365.029.","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"9685_CR15","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1177\/1933719116676395","volume":"24","author":"J Lima","year":"2017","unstructured":"Lima J, et al. Regulatory T cells show dynamic behavior during late pregnancy, delivery, and the postpartum period. Reprod Sci. 2017;24(7):1025\u201332. https:\/\/doi.org\/10.1177\/1933719116676395.","journal-title":"Reprod Sci"},{"issue":"6","key":"9685_CR16","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/cen.13843","volume":"89","author":"EG Sakkas","year":"2018","unstructured":"Sakkas EG, et al. Associations of maternal oestradiol, cortisol, and TGF-beta1 plasma concentrations with thyroid autoantibodies during pregnancy and postpartum. Clin Endocrinol (Oxf). 2018;89(6):789\u201397. https:\/\/doi.org\/10.1111\/cen.13843.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"9685_CR17","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/GRF.0000000000000430","volume":"62","author":"CT Nguyen","year":"2019","unstructured":"Nguyen CT, Mestman JH. Postpartum thyroiditis. Clin Obstet Gynecol. 2019;62(2):359\u201364. https:\/\/doi.org\/10.1097\/GRF.0000000000000430.","journal-title":"Clin Obstet Gynecol"},{"key":"9685_CR18","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fendo.2017.00166","volume":"8","author":"F Di Bari","year":"2017","unstructured":"Di Bari F, et al. Autoimmune abnormalities of postpartum thyroid diseases. Front Endocrinol (Lausanne). 2017;8:166. https:\/\/doi.org\/10.3389\/fendo.2017.00166.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9685_CR19","doi-asserted-by":"publisher","unstructured":"Hinck AP, Mueller TD, Springer TA. Structural biology and evolution of the TGF-beta family. Cold Spring Harb Perspect Biol.\u00a02016. https:\/\/doi.org\/10.1101\/cshperspect.a022103.","DOI":"10.1101\/cshperspect.a022103"},{"issue":"8","key":"9685_CR20","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1089\/thy.2007.0303","volume":"19","author":"MA Pisarev","year":"2009","unstructured":"Pisarev MA, Thomasz L, Juvenal GJ. Role of transforming growth factor beta in the regulation of thyroid function and growth. Thyroid. 2009;19(8):881\u201392. https:\/\/doi.org\/10.1089\/thy.2007.0303.","journal-title":"Thyroid"},{"issue":"14","key":"9685_CR21","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/j.febslet.2012.05.030","volume":"586","author":"J Massague","year":"2012","unstructured":"Massague J. TGF-beta signaling in development and disease. FEBS Lett. 2012;586(14):1833. https:\/\/doi.org\/10.1016\/j.febslet.2012.05.030.","journal-title":"FEBS Lett"},{"issue":"8\u20139","key":"9685_CR22","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.ejcb.2008.01.012","volume":"87","author":"PJ Wipff","year":"2008","unstructured":"Wipff PJ, Hinz B. Integrins and the activation of latent transforming growth factor beta1 - an intimate relationship. Eur J Cell Biol. 2008;87(8\u20139):601\u201315. https:\/\/doi.org\/10.1016\/j.ejcb.2008.01.012.","journal-title":"Eur J Cell Biol"},{"key":"9685_CR23","doi-asserted-by":"publisher","unstructured":"Heldin CH, Moustakas A. Signaling receptors for TGF-beta family members. Cold Spring Harb Perspect Biol.\u00a02016. https:\/\/doi.org\/10.1101\/cshperspect.a022053","DOI":"10.1101\/cshperspect.a022053"},{"key":"9685_CR24","doi-asserted-by":"publisher","unstructured":"Ark AV, Cao J, Li X. TGF-beta receptors: in and beyond TGF-beta signaling. Cell Signal.\u00a02018;52:112\u201320. https:\/\/doi.org\/10.1016\/j.cellsig.2018.09.002.","DOI":"10.1016\/j.cellsig.2018.09.002"},{"issue":"3","key":"9685_CR25","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1183\/09031936.06.00078405","volume":"28","author":"A Zandvoort","year":"2006","unstructured":"Zandvoort A, et al. Altered expression of the Smad signalling pathway: implications for COPD pathogenesis. Eur Respir J. 2006;28(3):533\u201341. https:\/\/doi.org\/10.1183\/09031936.06.00078405.","journal-title":"Eur Respir J"},{"key":"9685_CR26","doi-asserted-by":"publisher","unstructured":"Hata A, Chen YG. TGF-beta signaling from receptors to Smads. Cold Spring Harb Perspect Biol.\u00a02016. https:\/\/doi.org\/10.1101\/cshperspect.a022061","DOI":"10.1101\/cshperspect.a022061"},{"key":"9685_CR27","doi-asserted-by":"crossref","unstructured":"Zhang Y, Alexander PB, Wang XF. TGF-beta family signaling in the control of cell proliferation and survival. Cold Spring Harb Perspect Biol.\u00a02017;9(4).","DOI":"10.1101\/cshperspect.a022145"},{"issue":"1","key":"9685_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1101\/cshperspect.a022145","volume":"19","author":"YE Zhang","year":"2009","unstructured":"Zhang YE. Non-Smad pathways in TGF-beta signaling. Cell Res. 2009;19(1):128\u201339. https:\/\/doi.org\/10.1101\/cshperspect.a022145.","journal-title":"Cell Res"},{"issue":"6","key":"9685_CR29","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.immuni.2020.10.002","volume":"53","author":"JA Turner","year":"2020","unstructured":"Turner JA, et al. Regulatory T cell-derived TGF-beta1 controls multiple checkpoints governing allergy and autoimmunity. Immunity. 2020;53(6):1331\u20132. https:\/\/doi.org\/10.1016\/j.immuni.2020.10.002.","journal-title":"Immunity"},{"issue":"5","key":"9685_CR30","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/joim.12898","volume":"285","author":"A Egesten","year":"2019","unstructured":"Egesten A, Gordon S, Herwald H. Innate immunity - a clinical perspective. J Intern Med. 2019;285(5):477\u20138. https:\/\/doi.org\/10.1111\/joim.12898.","journal-title":"J Intern Med"},{"key":"9685_CR31","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/bs.ai.2017.01.001","volume":"134","author":"A Kelly","year":"2017","unstructured":"Kelly A, et al. Regulation of innate and adaptive immunity by TGFbeta. Adv Immunol. 2017;134:137\u2013233. https:\/\/doi.org\/10.1016\/bs.ai.2017.01.001.","journal-title":"Adv Immunol"},{"issue":"11","key":"9685_CR32","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1084\/jem.20012076","volume":"195","author":"L Gorelik","year":"2002","unstructured":"Gorelik L, Constant S, Flavell RA. Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation. J Exp Med. 2002;195(11):1499\u2013505. https:\/\/doi.org\/10.1084\/jem.20012076.","journal-title":"J Exp Med"},{"issue":"6","key":"9685_CR33","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.it.2010.04.002","volume":"31","author":"L Yang","year":"2010","unstructured":"Yang L, Pang Y, Moses HL. TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends Immunol. 2010;31(6):220\u20137. https:\/\/doi.org\/10.1016\/j.it.2010.04.002.","journal-title":"Trends Immunol"},{"issue":"4","key":"9685_CR34","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jaci.2013.01.046","volume":"131","author":"K Pieper","year":"2013","unstructured":"Pieper K, Grimbacher B, Eibel H. B-cell biology and development. J Allergy Clin Immunol. 2013;131(4):959\u201371. https:\/\/doi.org\/10.1016\/j.jaci.2013.01.046.","journal-title":"J Allergy Clin Immunol"},{"key":"9685_CR35","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.clim.2017.04.012","volume":"184","author":"MG Santaguida","year":"2017","unstructured":"Santaguida MG, et al. BREG cells in Hashimoto\u2019s thyroiditis isolated or associated to further organ-specific autoimmune diseases. Clin Immunol. 2017;184:42\u20137. https:\/\/doi.org\/10.1016\/j.clim.2017.04.012.","journal-title":"Clin Immunol"},{"key":"9685_CR36","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/431718","volume":"2011","author":"G Mincione","year":"2011","unstructured":"Mincione G, et al. EGF and TGF-beta1 effects on thyroid function. J Thyroid Res. 2011;2011: 431718. https:\/\/doi.org\/10.4061\/2011\/431718.","journal-title":"J Thyroid Res"},{"issue":"1","key":"9685_CR37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1677\/joe.0.1410045","volume":"141","author":"A Logan","year":"1994","unstructured":"Logan A, et al. Enhanced expression of transforming growth factor-beta 1 during thyroid hyperplasia in rats. J Endocrinol. 1994;141(1):45\u201357.","journal-title":"J Endocrinol"},{"issue":"1","key":"9685_CR38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1677\/joe.0.1410183","volume":"141","author":"AJ Cowin","year":"1994","unstructured":"Cowin AJ, Bidey SP. Transforming growth factor-beta 1 synthesis in human follicular thyroid cells: differential effects of iodide and plasminogen on the production of latent and active peptide forms. J Endocrinol. 1994;141(1):183\u201390.","journal-title":"J Endocrinol"},{"issue":"11","key":"9685_CR39","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/sj.onc.1201662","volume":"16","author":"C Carneiro","year":"1998","unstructured":"Carneiro C, et al. TGF-beta1 actions on FRTL-5 cells provide a model for the physiological regulation of thyroid growth. Oncogene. 1998;16(11):1455\u201365. https:\/\/doi.org\/10.1038\/sj.onc.1201662.","journal-title":"Oncogene"},{"issue":"1","key":"9685_CR40","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1210\/endo.142.1.7918","volume":"142","author":"HC Kang","year":"2001","unstructured":"Kang HC, et al. Pax-8 is essential for regulation of the thyroglobulin gene by transforming growth factor-beta1. Endocrinology. 2001;142(1):267\u201375. https:\/\/doi.org\/10.1210\/endo.142.1.7918.","journal-title":"Endocrinology"},{"issue":"4","key":"9685_CR41","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1210\/mend.14.4.0454","volume":"14","author":"G Napolitano","year":"2000","unstructured":"Napolitano G, et al. Transforming growth factor-beta1 down-regulation of major histocompatibility complex class I in thyrocytes: coordinate regulation of two separate elements by thyroid-specific as well as ubiquitous transcription factors. Mol Endocrinol. 2000;14(4):486\u2013505. https:\/\/doi.org\/10.1210\/mend.14.4.0454.","journal-title":"Mol Endocrinol"},{"issue":"4","key":"9685_CR42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1684\/ecn.2016.0382","volume":"27","author":"GC Martelossi Cebinelli","year":"2016","unstructured":"Martelossi Cebinelli GC, et al. TGF-beta1 functional polymorphisms: a review. Eur Cytokine Netw. 2016;27(4):81\u20139.","journal-title":"Eur Cytokine Netw"},{"key":"9685_CR43","doi-asserted-by":"publisher","unstructured":"Vural P, et al. Arg25Pro (c.915G>C) polymorphism of transforming growth factor beta1 gene suggests an association with increased risk for Hashimoto's thyroiditis. Int Immunopharmacol 2015;28(1):521\u20134. https:\/\/doi.org\/10.1016\/j.intimp.2015.07.019","DOI":"10.1016\/j.intimp.2015.07.019"},{"key":"9685_CR44","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/875125","volume":"2011","author":"AP Santin","year":"2011","unstructured":"Santin AP, Furlanetto TW. Role of estrogen in thyroid function and growth regulation. J Thyroid Res. 2011;2011: 875125. https:\/\/doi.org\/10.4061\/2011\/875125.","journal-title":"J Thyroid Res"},{"issue":"1\u20132","key":"9685_CR45","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.mce.2011.02.001","volume":"337","author":"MA Gantus","year":"2011","unstructured":"Gantus MA, et al. Estradiol modulates TGF-beta1 expression and its signaling pathway in thyroid stromal cells. Mol Cell Endocrinol. 2011;337(1\u20132):71\u20139. https:\/\/doi.org\/10.1016\/j.mce.2011.02.001.","journal-title":"Mol Cell Endocrinol"},{"key":"9685_CR46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.clim.2018.02.006","volume":"190","author":"J Qin","year":"2018","unstructured":"Qin J, et al. Estrogen receptor beta activation stimulates the development of experimental autoimmune thyroiditis through up-regulation of Th17-type responses. Clin Immunol. 2018;190:41\u201352. https:\/\/doi.org\/10.1016\/j.clim.2018.02.006.","journal-title":"Clin Immunol"},{"issue":"19","key":"9685_CR47","doi-asserted-by":"publisher","first-page":"14747","DOI":"10.1074\/jbc.M109.093039","volume":"285","author":"I Ito","year":"2010","unstructured":"Ito I, et al. Estrogen inhibits transforming growth factor beta signaling by promoting Smad2\/3 degradation. J Biol Chem. 2010;285(19):14747\u201355. https:\/\/doi.org\/10.1074\/jbc.M109.093039.","journal-title":"J Biol Chem"},{"issue":"1","key":"9685_CR48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1006\/jaut.1999.0339","volume":"14","author":"GJ Prud'homme","year":"2000","unstructured":"Prud\u2019homme GJ, Piccirillo CA. The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases. J Autoimmun. 2000;14(1):23\u201342. https:\/\/doi.org\/10.1006\/jaut.1999.0339.","journal-title":"J Autoimmun"},{"issue":"12","key":"9685_CR49","doi-asserted-by":"publisher","first-page":"5724","DOI":"10.1210\/en.2007-1024","volume":"148","author":"SM McLachlan","year":"2007","unstructured":"McLachlan SM, et al. The link between Graves\u2019 disease and Hashimoto\u2019s thyroiditis: a role for regulatory T cells. Endocrinology. 2007;148(12):5724\u201333. https:\/\/doi.org\/10.1210\/en.2007-1024.","journal-title":"Endocrinology"},{"issue":"4","key":"9685_CR50","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/0896-8411(91)90186-g","volume":"4","author":"J Widder","year":"1991","unstructured":"Widder J, et al. The immunoregulatory influence of transforming growth factor beta in thyroid autoimmunity: TGF beta inhibits autoreactivity in Graves\u2019 disease. J Autoimmun. 1991;4(4):689\u2013701. https:\/\/doi.org\/10.1016\/0896-8411(91)90186-g.","journal-title":"J Autoimmun"},{"issue":"2","key":"9685_CR51","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1042\/BSR20180143","volume":"13","author":"F Kutluturk","year":"2013","unstructured":"Kutluturk F, et al. Association of cytokine gene polymorphisms (IL6, IL10, TNF-alpha, TGF-beta and IFN-gamma) and Graves\u2019 disease in Turkish population. Endocr Metab Immune Disord Drug Targets. 2013;13(2):163\u20137. https:\/\/doi.org\/10.1042\/BSR20180143.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"3","key":"9685_CR52","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1365-2249.2007.03575.x","volume":"151","author":"H Yamada","year":"2008","unstructured":"Yamada H, et al. The +869T\/C polymorphism in the transforming growth factor-beta1 gene is associated with the severity and intractability of autoimmune thyroid disease. Clin Exp Immunol. 2008;151(3):379\u201382. https:\/\/doi.org\/10.1111\/j.1365-2249.2007.03575.x.","journal-title":"Clin Exp Immunol"},{"key":"9685_CR53","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1210\/jc.2008-1732","volume":"94","author":"A Yoshida","year":"2009","unstructured":"Yoshida A, Hisatome I, Taniguchi S, et al. Pendrin is a novel autoantigen recognized by patients with autoimmune thyroid diseases. J Clin Endocrinol Metab. 2009;94:442\u20138. https:\/\/doi.org\/10.1210\/jc.2008-1732.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"9685_CR54","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.arcmed.2007.12.001","volume":"39","author":"B Akinci","year":"2008","unstructured":"Akinci B, et al. Hashimoto\u2019s thyroiditis, but not treatment of hypothyroidism, is associated with altered TGF-beta1 levels. Arch Med Res. 2008;39(4):397\u2013401. https:\/\/doi.org\/10.1016\/j.arcmed.2007.12.001.","journal-title":"Arch Med Res"},{"issue":"1","key":"9685_CR55","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jaut.2009.03.010","volume":"33","author":"GP Morris","year":"2009","unstructured":"Morris GP, Brown NK, Kong YC. Naturally-existing CD4(+)CD25(+)Foxp3(+) regulatory T cells are required for tolerance to experimental autoimmune thyroiditis induced by either exogenous or endogenous autoantigen. J Autoimmun. 2009;33(1):68\u201376. https:\/\/doi.org\/10.1016\/j.jaut.2009.03.010.","journal-title":"J Autoimmun"},{"key":"9685_CR56","doi-asserted-by":"crossref","unstructured":"Braley-Mullen H, et al. Role of TGFbeta in development of spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. J Immunol.\u00a02001;167(12):7111\u20138.","DOI":"10.4049\/jimmunol.167.12.7111"},{"issue":"11","key":"9685_CR57","doi-asserted-by":"publisher","first-page":"6236","DOI":"10.4049\/jimmunol.171.11.6236","volume":"171","author":"K Chen","year":"2003","unstructured":"Chen K, et al. Mechanisms of spontaneous resolution versus fibrosis in granulomatous experimental autoimmune thyroiditis. J Immunol. 2003;171(11):6236\u201343.","journal-title":"J Immunol"},{"issue":"6","key":"9685_CR58","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1189\/jlb.68.6.828","volume":"68","author":"K Chen","year":"2000","unstructured":"Chen K, et al. Characterization of thyroid fibrosis in a murine model of granulomatous experimental autoimmune thyroiditis. J Leukoc Biol. 2000;68(6):828\u201335.","journal-title":"J Leukoc Biol"},{"key":"9685_CR59","doi-asserted-by":"publisher","first-page":"7453260","DOI":"10.1155\/2019\/7453260","volume":"2019","author":"D Lacheta","year":"2019","unstructured":"Lacheta D, et al. Immunological aspects of graves\u2019 ophthalmopathy. Biomed Res Int. 2019;2019:7453260. https:\/\/doi.org\/10.1155\/2019\/7453260.","journal-title":"Biomed Res Int"},{"key":"9685_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yexmp.2018.11.004","volume":"106","author":"CM Longo","year":"2019","unstructured":"Longo CM, Higgins PJ. Molecular biomarkers of Graves\u2019 ophthalmopathy. Exp Mol Pathol. 2019;106:1\u20136. https:\/\/doi.org\/10.1016\/j.yexmp.2018.11.004.","journal-title":"Exp Mol Pathol"},{"issue":"12","key":"9685_CR61","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1089\/thy.2008.0255","volume":"18","author":"TK Khoo","year":"2008","unstructured":"Khoo TK, et al. Evidence for enhanced Thy-1 (CD90) expression in OFs of patients with Graves\u2019 ophthalmopathy. Thyroid. 2008;18(12):1291\u20136. https:\/\/doi.org\/10.1089\/thy.2008.0255.","journal-title":"Thyroid"},{"issue":"2","key":"9685_CR62","first-page":"903","volume":"86","author":"RW Valyasevi","year":"2001","unstructured":"Valyasevi RW, et al. Effect of tumor necrosis factor-alpha, interferon-gamma, and transforming growth factor-beta on adipogenesis and expression of thyrotropin receptor in human orbital preadipocyte fibroblasts. J Clin Endocrinol Metab. 2001;86(2):903\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"9685_CR63","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1167\/iovs.16-20684","volume":"58","author":"J Ko","year":"2017","unstructured":"Ko J, et al. Sphingosine-1-phosphate mediates fibrosis in orbital fibroblasts in graves\u2019 orbitopathy. Invest Ophthalmol Vis Sci. 2017;58(5):2544\u201353. https:\/\/doi.org\/10.1167\/iovs.16-20684.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"9685_CR64","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1210\/jc.2017-0134972","volume":"102","author":"S Fang","year":"2017","unstructured":"Fang S, et al. Regulation of orbital fibrosis and adipogenesis by pathogenic Th17 cells in graves orbitopathy. J Clin Endocrinol Metab. 2017;102(11):4273\u201383. https:\/\/doi.org\/10.1210\/jc.2017-0134972.","journal-title":"J Clin Endocrinol Metab"},{"issue":"20","key":"9685_CR65","first-page":"4680","volume":"21","author":"LF Lv","year":"2017","unstructured":"Lv LF, et al. Expression level and clinical significance of IL-2, IL-6 and TGF-beta in elderly patients with goiter and hyperthyroidism. Eur Rev Med Pharmacol Sci. 2017;21(20):4680\u20136.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"9685_CR66","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1159\/000242477","volume":"30","author":"JY Seo","year":"2009","unstructured":"Seo JY, et al. Positive feedback loop between plasminogen activator inhibitor-1 and transforming growth factor-beta1 during renal fibrosis in diabetes. Am J Nephrol. 2009;30(6):481\u201390. https:\/\/doi.org\/10.1159\/000242477.","journal-title":"Am J Nephrol"},{"issue":"4","key":"9685_CR67","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3109\/13816810.2010.515648","volume":"31","author":"O Khalilzadeh","year":"2010","unstructured":"Khalilzadeh O, et al. Genetic susceptibility to Graves\u2019 ophthalmopathy: the role of polymorphisms in anti-inflammatory cytokine genes. Ophthalmic Genet. 2010;31(4):215\u201320. https:\/\/doi.org\/10.3109\/13816810.2010.515648.","journal-title":"Ophthalmic Genet"},{"issue":"7","key":"9685_CR68","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1089\/thy.1999.9.675","volume":"9","author":"TF Davies","year":"1999","unstructured":"Davies TF. The thyroid immunology of the postpartum period. Thyroid. 1999;9(7):675\u201384. https:\/\/doi.org\/10.1089\/thy.1999.9.675.","journal-title":"Thyroid"},{"key":"9685_CR69","volume-title":"The role of regulatory T-cells (Tregs) in pregnancy, pre-eclampsia and beyond","author":"A Miedema","year":"2016","unstructured":"Miedema A. The role of regulatory T-cells (Tregs) in pregnancy, pre-eclampsia and beyond. Essay. Master. Biomedical Sciences: Univercity of Gronigen; 2016."},{"key":"9685_CR70","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/31846478","volume":"2013","author":"M Singh","year":"2013","unstructured":"Singh M, et al. Changes in maternal serum transforming growth factor beta-1 during pregnancy: a cross-sectional study. Biomed Res Int. 2013;2013: 318464. https:\/\/doi.org\/10.1155\/2013\/31846478.","journal-title":"Biomed Res Int"},{"issue":"1","key":"9685_CR71","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cyto.2012.06.005","volume":"60","author":"DD Briana","year":"2012","unstructured":"Briana DD, et al. Fetal concentrations of the growth factors TGF-alpha and TGF-beta1 in relation to normal and restricted fetal growth at term. Cytokine. 2012;60(1):157\u201361. https:\/\/doi.org\/10.1016\/j.cyto.2012.06.005.","journal-title":"Cytokine"},{"issue":"1","key":"9685_CR72","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1677\/joe.0.1760069","volume":"176","author":"P Liakos","year":"2003","unstructured":"Liakos P, et al. Transforming growth factor beta1 inhibits aldosterone and cortisol production in the human adrenocortical cell line NCI-H295R through inhibition of CYP11B1 and CYP11B2 expression. J Endocrinol. 2003;176(1):69\u201382.","journal-title":"J Endocrinol"},{"key":"9685_CR73","doi-asserted-by":"crossref","unstructured":"LiVolsi VA. Postpartum thyroiditis. The pathology slowly unravels. Am J Clin Pathol.\u00a01993;100(3):193\u20135.","DOI":"10.1093\/ajcp\/100.3.193"},{"issue":"4","key":"9685_CR74","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/00003072-199304000-00007","volume":"18","author":"CM Intenzo","year":"1993","unstructured":"Intenzo CM, et al. Clinical, laboratory, and scintigraphic manifestations of subacute and chronic thyroiditis. Clin Nucl Med. 1993;18(4):302\u20136. https:\/\/doi.org\/10.1097\/00003072-199304000-00007.","journal-title":"Clin Nucl Med"},{"issue":"7","key":"9685_CR75","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S2213-8587(17)30402-3","volume":"6","author":"S De Leo","year":"2018","unstructured":"De Leo S, Pearce EN. Autoimmune thyroid disease during pregnancy. Lancet Diabetes Endocrinol. 2018;6(7):575\u201386. https:\/\/doi.org\/10.1016\/S2213-8587(17)30402-3.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"9685_CR76","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1210\/jc.2002-020990","volume":"88","author":"A Olivieri","year":"2003","unstructured":"Olivieri A, et al. Postpartum thyroiditis is associated with fluctuations in transforming growth factor-beta1 serum levels. J Clin Endocrinol Metab. 2003;88(3):1280\u20134. https:\/\/doi.org\/10.1210\/jc.2002-020990.","journal-title":"J Clin Endocrinol Metab"},{"issue":"418","key":"9685_CR77","first-page":"305","volume":"47","author":"JH Lazarus","year":"1997","unstructured":"Lazarus JH, et al. Clinical aspects of recurrent postpartum thyroiditis. Br J Gen Pract. 1997;47(418):305\u20138.","journal-title":"Br J Gen Pract"},{"issue":"6","key":"9685_CR78","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1210\/js.2018-00090","volume":"2","author":"S Maraka","year":"2018","unstructured":"Maraka S, et al. Subclinical hypothyroidism in women planning conception and during pregnancy: who should be treated and how? J Endocr Soc. 2018;2(6):533\u201346. https:\/\/doi.org\/10.1210\/js.2018-00090.","journal-title":"J Endocr Soc"},{"issue":"1","key":"9685_CR79","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1046\/j.1523-1755.2002.00119.x","volume":"61","author":"S Stefoni","year":"2002","unstructured":"Stefoni S, et al. Low TGF-beta1 serum levels are a risk factor for atherosclerosis disease in ESRD patients. Kidney Int. 2002;61(1):324\u201335. https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00119.x.","journal-title":"Kidney Int"},{"key":"9685_CR80","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3389\/fnins.2019.01107","volume":"13","author":"SS Duffy","year":"2019","unstructured":"Duffy SS, Keating BA, Moalem-Taylor G. Adoptive transfer of regulatory T cells as a promising immunotherapy for the treatment of multiple sclerosis. Front Neurosci. 2019;13:1107. https:\/\/doi.org\/10.3389\/fnins.2019.01107.","journal-title":"Front Neurosci"},{"issue":"1","key":"9685_CR81","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3109\/08916931003782163","volume":"44","author":"X Zhou","year":"2011","unstructured":"Zhou X, et al. Therapeutic potential of TGF-beta-induced CD4(+) Foxp3(+) regulatory T cells in autoimmune diseases. Autoimmunity. 2011;44(1):43\u201350. https:\/\/doi.org\/10.3109\/08916931003782163.","journal-title":"Autoimmunity"},{"issue":"2","key":"9685_CR82","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1074\/jbc.M108855200","volume":"277","author":"JE Chipuk","year":"2002","unstructured":"Chipuk JE, et al. The androgen receptor represses transforming growth factor-beta signaling through interaction with Smad3. J Biol Chem. 2002;277(2):1240\u20138. https:\/\/doi.org\/10.1074\/jbc.M108855200.","journal-title":"J Biol Chem"},{"issue":"1","key":"9685_CR83","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/neuonc\/noq142","volume":"13","author":"U Bogdahn","year":"2011","unstructured":"Bogdahn U, et al. Targeted therapy for high-grade glioma with the TGF-beta2 inhibitor trabedersen: results of a randomized and controlled phase IIb study. Neuro Oncol. 2011;13(1):132\u201342. https:\/\/doi.org\/10.1093\/neuonc\/noq142.","journal-title":"Neuro Oncol"},{"key":"9685_CR84","doi-asserted-by":"publisher","unstructured":"Akhurst RJ. Targeting TGF-beta signaling for therapeutic gain. Cold Spring Harb Perspect Biol.\u00a02017. https:\/\/doi.org\/10.1101\/cshperspect.a022301.","DOI":"10.1101\/cshperspect.a022301"},{"issue":"5","key":"9685_CR85","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/jcb.20594","volume":"97","author":"KR Cutroneo","year":"2006","unstructured":"Cutroneo KR. Evidence for TGF-beta1 and bleomycin intracellular signaling through autocrine regulation of Smad 3 binding to the proximal promoter of the Smad 7 gene. J Cell Biochem. 2006;97(5):933\u20139. https:\/\/doi.org\/10.1002\/jcb.20594.","journal-title":"J Cell Biochem"},{"key":"9685_CR86","doi-asserted-by":"publisher","unstructured":"Azimi A. Pentoxifylline explores new horizons in treatment of Hashimoto thyroiditis. Biol Med.\u00a02016. https:\/\/doi.org\/10.4172\/0974-8369.1000293.","DOI":"10.4172\/0974-8369.1000293"},{"issue":"7","key":"9685_CR87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200661","volume":"13","author":"S Kunzmann","year":"2018","unstructured":"Kunzmann S, et al. Effect of progesterone on Smad signaling and TGF-beta\/Smad-regulated genes in lung epithelial cells. PLoS One. 2018;13(7): e0200661. https:\/\/doi.org\/10.1371\/journal.pone.0200661.","journal-title":"PLoS ONE"},{"issue":"7","key":"9685_CR88","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/bjs.9765","volume":"102","author":"H Kuroki","year":"2015","unstructured":"Kuroki H, et al. Effect of LSKL peptide on thrombospondin 1-mediated transforming growth factor beta signal activation and liver regeneration after hepatectomy in an experimental model. Br J Surg. 2015;102(7):813\u201325. https:\/\/doi.org\/10.1002\/bjs.9765.","journal-title":"Br J Surg"},{"issue":"8","key":"9685_CR89","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1089\/pho.2014.3716","volume":"32","author":"DB Hofling","year":"2014","unstructured":"Hofling DB, et al. Effects of low-level laser therapy on the serum TGF-beta1 concentrations in individuals with autoimmune thyroiditis. Photomed Laser Surg. 2014;32(8):444\u20139. https:\/\/doi.org\/10.1089\/pho.2014.3716.","journal-title":"Photomed Laser Surg"},{"key":"9685_CR90","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.matbio.2017.12.016","volume":"68\u201369","author":"AH Gyorfi","year":"2018","unstructured":"Gyorfi AH, Matei AE, Distler JHW. Targeting TGF-beta signaling for the treatment of fibrosis. Matrix Biol. 2018;68\u201369:8\u201327. https:\/\/doi.org\/10.1016\/j.matbio.2017.12.016.","journal-title":"Matrix Biol"},{"issue":"4","key":"9685_CR91","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1167\/iovs.15-18018","volume":"57","author":"AM Cheng","year":"2016","unstructured":"Cheng AM, et al. Celecoxib and pioglitazone as potential therapeutics for regulating TGF-beta-induced hyaluronan in dysthyroid myopathy. Invest Ophthalmol Vis Sci. 2016;57(4):1951\u20139. https:\/\/doi.org\/10.1167\/iovs.15-18018.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9685_CR92","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.ejmech.2015.01.010","volume":"92","author":"A Rouch","year":"2015","unstructured":"Rouch A, et al. Small molecules inhibitors of plasminogen activator inhibitor-1 - an overview. Eur J Med Chem. 2015;92:619\u201336. https:\/\/doi.org\/10.1016\/j.ejmech.2015.01.010.","journal-title":"Eur J Med Chem"},{"issue":"10","key":"9685_CR93","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/BF03348195","volume":"26","author":"G Mastorakos","year":"2003","unstructured":"Mastorakos G, et al. T4 but not T3 administration is associated with increased recurrence of Graves\u2019 disease after successful medical therapy. J Endocrinol Invest. 2003;26(10):979\u201384. https:\/\/doi.org\/10.1007\/BF03348195.","journal-title":"J Endocrinol Invest"},{"issue":"24","key":"9685_CR94","doi-asserted-by":"publisher","first-page":"E3451","DOI":"10.1073\/pnas.1506113113","volume":"113","author":"E Alonso-Merino","year":"2016","unstructured":"Alonso-Merino E, et al. Thyroid hormones inhibit TGF-beta signaling and attenuate fibrotic responses. Proc Natl Acad Sci USA. 2016;113(24):E3451\u201360. https:\/\/doi.org\/10.1073\/pnas.1506113113.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"9685_CR95","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","volume":"50","author":"E Batlle","year":"2019","unstructured":"Batlle E, Massague J. Transforming growth factor-beta signaling in immunity and cancer. Immunity. 2019;50(4):924\u201340.","journal-title":"Immunity"},{"key":"9685_CR96","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.2741\/1859","volume":"11","author":"S Huber","year":"2006","unstructured":"Huber S, Schramm C. TGF-beta and CD4+CD25+ regulatory T cells. Front Biosci. 2006;11:1014\u201323. https:\/\/doi.org\/10.2741\/1859.","journal-title":"Front Biosci"},{"issue":"2","key":"9685_CR97","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nri.2015.10","volume":"16","author":"BJ Laidlaw","year":"2016","unstructured":"Laidlaw BJ, Craft JE, Kaech SM. The multifaceted role of CD4(+) T cells in CD8(+) T cell memory. Nat Rev Immunol. 2016;16(2):102\u201311.","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"9685_CR98","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.2337\/db08-0609","volume":"57","author":"CM Filippi","year":"2008","unstructured":"Filippi CM, et al. Transforming growth factor-beta suppresses the activation of CD8+ T-cells when naive but promotes their survival and function once antigen experienced: a two-faced impact on autoimmunity. Diabetes. 2008;57(10):2684\u201392. https:\/\/doi.org\/10.2337\/db08-0609.","journal-title":"Diabetes"},{"issue":"2","key":"9685_CR99","doi-asserted-by":"publisher","first-page":"594","DOI":"10.4049\/jimmunol.1102389","volume":"188","author":"K Ganeshan","year":"2012","unstructured":"Ganeshan K, Bryce PJ. Regulatory T cells enhance mast cell production of IL-6 via surface-bound TGF-beta. J Immunol. 2012;188(2):594\u2013603. https:\/\/doi.org\/10.4049\/jimmunol.1102389.","journal-title":"J Immunol"},{"issue":"4","key":"9685_CR100","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S1074-7613(00)00044-3","volume":"13","author":"BB Cazac","year":"2000","unstructured":"Cazac BB, Roes J. TGF-beta receptor controls B cell responsiveness and induction of IgA in vivo. Immunity. 2000;13(4):443\u201351. https:\/\/doi.org\/10.1016\/S1074-7613(00)00044-3.","journal-title":"Immunity"},{"issue":"3","key":"9685_CR101","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.cell.2008.07.025","volume":"134","author":"MO Li","year":"2008","unstructured":"Li MO, Flavell RA. TGF-beta: a master of all T cell trades. Cell. 2008;134(3):392\u2013404. https:\/\/doi.org\/10.1016\/j.cell.2008.07.025.","journal-title":"Cell"},{"issue":"8","key":"9685_CR102","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.4049\/jimmunol.1301843","volume":"191","author":"SA Oh","year":"2013","unstructured":"Oh SA, Li MO. TGF-beta: guardian of T cell function. J Immunol. 2013;191(8):3973\u20139.","journal-title":"J Immunol"},{"issue":"4","key":"9685_CR103","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.immuni.2017.03.015","volume":"46","author":"JE Konkel","year":"2017","unstructured":"Konkel JE, et al. Transforming growth factor-beta signaling in regulatory T cells controls T Helper-17 cells and tissue-specific immune responses. Immunity. 2017;46(4):660\u201374. https:\/\/doi.org\/10.1016\/j.immuni.2017.03.015.","journal-title":"Immunity"},{"issue":"4","key":"9685_CR104","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/cdd.2008.183","volume":"16","author":"LC Spender","year":"2009","unstructured":"Spender LC, et al. TGF-beta induces apoptosis in human B cells by transcriptional regulation of BIK and BCL-XL. Cell Death Differ. 2009;16(4):593\u2013602. https:\/\/doi.org\/10.1038\/cdd.2008.183.","journal-title":"Cell Death Differ"}],"updated-by":[{"DOI":"10.1007\/s11154-022-09722-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000}}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-021-09685-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-021-09685-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-021-09685-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T11:30:14Z","timestamp":1673263814000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-021-09685-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,16]]},"references-count":104,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["9685"],"URL":"https:\/\/doi.org\/10.1007\/s11154-021-09685-7","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s11154-022-09722-z","asserted-by":"object"}]},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,16]]},"assertion":[{"value":"30 August 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2022","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11154-022-09722-z","URL":"https:\/\/doi.org\/10.1007\/s11154-022-09722-z","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is no potential conflict of interest for the authors and the authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}